Transdermal Skin Patches Market
Global Transdermal Skin Patches Market Size, Share and Trends Analysis Report, By Type (Single-Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others), By Application (Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others), Forecast (2022-2028) Update Available - Forecast 2024-2030
The global transdermal skin patches market is anticipated to grow at a significant CAGR of around 4.5% during the forecast period (2022-2028). The transdermal patch is a type of transdermal technology. It is a medicated adhesive patch that is placed on the skin to deliver a precise dose of medication. These patches deliver medicine dosage through the skin using a diffusion technique, which gets released into the bloodstream over a long period. The factors such as adoption of transdermal medicine over oral and ingesting medications due to its advantages like elimination of pain, possibility of infection, and risk of disease transmission by needle reuse, is accelerating the market growth. In addition, the new product introduced by the prominent players in the market is also contributing to the development of the market. For instance, in June 2021, Luye Pharma Group launched the Rivastigmine Transdermal Patch in China for the treatment of mild to moderate Alzheimer's disease. Currently, delivery of the transdermal system is increasing in demand due to reduced dosing frequency, improved bioavailability, reduced adverse events, and drug input termination at any point by the removal of the patch.
However, the variations in inter- and intraindividual absorption of drugs applied to the skin may restrains the adoption of transdermal skin patches on wider level. Moreover, investments for drug development and new product development by government can offer lucrative market growth opportunities during forecasted period.
Impact of COVID-19 on Global Transdermal Skin Patches Market
The COVID-19 pandemic has impacted the global economy due to lockdown. But the COVID-19 outbreak is expected to positively impact the transdermal skin patches market. These patches enable safe, reproducible, and controlled administration of drugs to a defined skin microenvironment. Therefore, researchers are on a potential vaccine against the new COVID-19 strain are exploring the uses of a fingertip-sized skin patch for delivery.
Segmental Outlook
The global transdermal skin patches market is segmented based on the type and application. Based on the type the market is sub-segmented into single-layer drugs in adhesive, multi-layer drug-in-adhesive, matrix, and others. Based on the application the market is sub-segmented into pain relief, smoking reduction and cessation aid, overactive bladder, hormonal therapy, and others. The above-mentioned segments can be customized as per the requirements.
Global Transdermal Skin Patches Market Share by Application, 2021 (%)
Smoking Reduction and Cessation Aid Segment is anticipated to hold a prominent share in the Global Transdermal Skin Patches Market
The segment’s growth rate is attributed to a large number of smokers globally and increasing awareness about the advantages of the transdermal route of administration of drugs for smoking cessation. Cigarette smoking is not only the most common form of tobacco use but one of the leading preventable risk factors for early mortality globally.,. Nicotine transdermal skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped. Therefore, with the increasing number of smokers with associated diseases such as erectile dysfunction in males, cancer, heart disease, stroke, lung diseases, diabetes, and chronic obstructive globally, the demand for transdermal skin patches (nicotine) is expected to increase in emerging economies during the forecast period. As per the CDC, more than 16 million Americans are living with a disease caused by smoking, and cigarette smoking is responsible for more than 480,000 deaths per year in the US.
Regional Outlooks
The global transdermal skin patches market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). North America is expected to hold the highest share throughout the forecast period. The regional growth is attributed to the presence of key players and established healthcare infrastructure in region’s major economies. In addition, supportive healthcare policies, and a high number of patients in the US is another factor for market growth in North America.
Global Transdermal Skin Patches Market Growth, by Region 2022-2028
The Asia-Pacific region is estimated to be the fastest growing in the Global Transdermal Skin Patches Market
The Asia-Pacific has emerged as the fastest-growing region in the transdermal skin patches market due to rising demand for better treatment at affordable cost in the region. Furthermore, innovation and government funding in the development of cutting-edge technology and healthcare infrastructure would augment the growth of the Asia pacific transdermal skin patches market.
Market Players Outlook
The major companies serving the global transdermal skin patches market include Novartis International AG, Teva Pharmaceuticals USA Inc., The 3M Co., Mylan N.V., Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers& acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2020, AbbVie Inc. had set forth RINVOQ that is considered to be continuously evaluated across multiple inflammatory diseases for effective outcomes.
The report covers
- Market value data analysis of 2022 and forecast to 2028
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global transdermal skin patches market.
- Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Transdermal Skin Patches Market
• Recovery Scenario of Global Transdermal Skin Patches Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Type
1.2.2. BY Application
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Teva Pharmaceuticals USA Inc
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. The 3M Co
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Novartis International AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Mylan N.V
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Pfizer Inc
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Transdermal Skin Patches Market by Type
4.1.1. Single Layer Drug-in-Adhesive
4.1.2. Multi-Layer Drug-in-Adhesive
4.1.3. Matrix
4.1.4. Others
4.2. Global Transdermal Skin Patches Market by Application
4.2.1. Pain Relief
4.2.2. Smoking Reduction & Cessation Aid
4.2.3.
4.2.4. Overactive Bladder
4.2.5. Hormonal Therapy
4.2.6. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1 Latin America
5.4.2 Middle East and Africa
6. Company Profiles
6.1. InteRNA Technologies B.V.
6.2. Novartis AG
6.3. OrchidPharma Ltd
6.4. Apotex Inc
6.5. Alembic Ltd
6.6. Cadila Pharmaceuticals
6.7. Aurobindo Pharma Ltd
6.8. Ajanta Pharma Ltd
6.9. AdhexPharma
6.10. Macleods Pharmaceuticals Ltd
6.11. Dr. Reddy’s Laboratories Ltd
6.12. Pfizer Inc
6.13. Mylan N.V
6.14. Teikoku Pharma USA Inc.
6.15. Luye Pharma Group
6.16. Purdue Pharma Manufacturing LP
1. GLOBAL TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL SINGLE LAYER DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
3. GLOBAL MULTILAYER DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
4. GLOBAL MATRIX DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
5. GLOBAL OTHERS DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7. GLOBAL TRANSDERMAL SKIN PATCHES IN PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
8. GLOBAL TRANSDERMAL SKIN PATCHES IN SMOKING REDUCTION & CESSATION AID MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
9. GLOBAL OVERACTIVE BLADDER TRANSDERMAL SKIN PATCHES IN CESSATION AID MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
10. GLOBAL TRANSDERMAL SKIN PATCHES IN HORMONAL THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11. GLOBAL TRANSDERMAL SKIN PATCHES IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
12. GLOBAL TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
14. NORTH AMERICAN TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
15. EUROPEAN TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16. EUROPEAN TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. REST OF THE WORLD TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. REST OF THE WORLD TRANSDERMAL SKIN PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL SKIN PATCHES MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL SKIN PATCHES MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL TRANSDERMAL SKIN PATCHES MARKET, 2021-2028 (%)
4. GLOBAL TRANSDERMAL SKIN PATCHES MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL SINGLE LAYER DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS2028 (%)
6. GLOBAL MULTILAYER DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES SHARE BY GEOGRAPHY , 2021 VS 2028 (%)
7. GLOBAL MATRIX DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OTHERS DRUG-IN-ADHESIVE TRANSDERMAL SKIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS2028 (%)
9. GLOBAL TRANSDERMAL SKIN PATCHES MARKET BY APPLICATION, 2021 VS2028 (%)
10. GLOBAL PAIN RELIEF TRANSDERMAL SKIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS2028 (%)
11. GLOBAL TRANSDERMAL SKIN PATCHES IN SMOKING REDUCTION & CESSATION AID MARKET SHARE BY GEOGRAPHY BY APPLICATION, 2021 VS2028 (%)
12. GLOBAL TRANSDERMAL SKIN PATCHES IN OVERACTIVE BLADDER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL TRANSDERMAL SKIN PATCHES IN HORMONAL THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS2028 (%)
14. GLOBAL TRANSDERMAL SKIN PATCHES IN OTHER APPLICATIONS MARKET SHARE BY GEOGRAPHY, 2021 VS2028 (%)
15. GLOBAL TRANSDERMAL SKIN PATCHES MARKET BY GEOGRAPHY, 2021-2028 ($ MILLION)
16. US GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
17. CANADA GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
18. UK GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE GLOBAL TRANSDERMAL SKIN PATCHES MARKET, 2021-2028 ($ MILLION)
20. GERMANY GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
21. ITALY GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
22. SPAIN GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF EUROPE GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
24. INDIA GLOBAL TRANSDERMAL SKIN PATCHES MARKET, 2021-2028 ($ MILLION)
25. CHINA GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
26. JAPAN GLOBAL TRANSDERMAL SKIN PATCHES MARKET, 2021-2028 ($ MILLION)
27. SOUTH KOREA GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF ASIA-PACIFIC GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF THE WORLD GLOBAL TRANSDERMAL SKIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
